NCI-60 whole exome sequencing and pharmacological CellMiner analyses
about
Using CellMiner 1.6 for Systems Pharmacology and Genomic Analysis of the NCI-60Using drug response data to identify molecular effectors, and molecular "omic" data to identify candidate drugs in cancerUsing Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer TherapyThe NCI-60 Methylome and Its Integration into CellMiner.Role of Merlin/NF2 inactivation in tumor biology.Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assayRobust in-silico identification of cancer cell lines based on next generation sequencing.Correlation between Gene Variants, Signaling Pathways, and Efficacy of Chemotherapy Drugs against Colon CancersZebrafish: a new companion for translational research in oncology.Quality control material for the detection of somatic mutations in fixed clinical specimens by next-generation sequencing.Targeting DNA repair and replication stress in the treatment of ovarian cancer.Distribution bias and biochemical characterization of TOP1MT single nucleotide variants.A ribonucleotide reductase inhibitor with deoxyribonucleoside-reversible cytotoxicity.Bioinformatics Approaches to Predict Drug Responses from Genomic Sequencing.STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion.Synthesis and Biological Evaluation of New Madecassic Acid Derivatives Targeting ERK Cascade Signaling
P2860
Q26826831-F45639BB-A0F9-494E-AEC7-0BC7F8D229AAQ27320602-4C7A1AC4-F891-433A-8D55-91A6A9A30C1EQ28076097-092C1631-C4CB-4081-BA24-22E3B5AD059EQ30490461-81B00A95-3745-499F-936E-D780D63ADEACQ36189820-B8381EDB-8501-429C-A2A1-50F51257F4F8Q36270038-991A3989-E1FE-4033-AB0D-22B9E7C02168Q36348889-6D73A18E-895D-44E8-8112-A73D00C43B90Q36487348-C7C0B6C5-F652-411C-9318-764BBC91AC39Q38312265-695031C1-33F9-45FF-AFF9-D96CDE763E2FQ38834954-9773C088-A3ED-4D57-AF80-3616E5C998E9Q39393235-78526682-A48A-4C34-BDB2-9928BC45D7B4Q41447217-38A760CD-4455-4A14-8F34-18E5D7043224Q42282773-31582314-0A77-4EDE-A027-47E2839C4D39Q47726158-8C0FFD9B-3793-44BC-9DA6-EC8ED70E5532Q50042688-50EEEAC6-F2BF-4D18-B1EC-954310AE1569Q57490053-D0684D3E-E440-410C-BDAC-BDFE591CD018
P2860
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@ast
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@en
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@nl
type
label
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@ast
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@en
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@nl
prefLabel
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@ast
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@en
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@nl
P2093
P2860
P50
P3181
P1433
P1476
NCI-60 whole exome sequencing and pharmacological CellMiner analyses
@en
P2093
James H Doroshow
Joel Morris
Kurt W Kohn
Margot Sunshine
Ogan D Abaan
Paul S Meltzer
Spencer W Reinhold
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0101670
P407
P577
2014-01-01T00:00:00Z